Business Context and Reporting Period
Company: InnovAge Holding Corp. (INNV)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended December 31, 2025
Business Overview: InnovAge is the largest PACE (Program of All-Inclusive Care for the Elderly) provider in the U.S., serving approximately 8,010 frail, dual-eligible seniors across 20 centers in California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. The company operates on a fully capitated model, bearing 100% of the financial risk for participant healthcare costs.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Dec 31, 2025 | Six Months Ended Dec 31, 2025 | Six Months Ended Dec 31, 2024 |
|---|---|---|---|
| Total Revenues | $239,708 | $475,813 | $414,141 |
| Operating Income | $13,262 | $21,551 | $(17,452) |
| Net Income (Attributable to InnovAge) | $10,618 | $18,637 | $(18,150) |
| EPS (Diluted) | $0.08 | $0.14 | $(0.13) |
| Center-Level Contribution Margin | $52,825 | $104,182 | $71,607 |
| Adjusted EBITDA | $22,151 | $39,794 | $12,346 |
| Cash and Cash Equivalents | $83,203 (as of Dec 31, 2025) | N/A | |
| Total Debt Outstanding | $59,448 (as of Dec 31, 2025) | N/A |
Liquidity: As of December 31, 2025, the company held $83.2 million in cash and cash equivalents and $42.8 million in short-term investments. The company has $84.4 million of remaining borrowing capacity under its Revolving Credit Facility.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 14.7% year-over-year for the three months ended December 31, 2025, and 14.9% for the six-month period. This was driven by a 6.4% increase in capitation rates and a 7.9% increase in member months.
- Profitability Turnaround: The company returned to profitability, reporting net income of $10.6 million for the quarter and $18.6 million for the six months, compared to net losses of $13.2 million and $18.2 million in the respective prior-year periods.
- Cost Dynamics: Cost of care (excluding D&A) increased 16.9% quarter-over-quarter, primarily due to higher wage rates, organizational restructuring, and costs associated with transitioning to in-house pharmacy services. However, external provider costs per participant decreased due to lower nursing facility utilization and pharmacy expense reductions.
- Asset Disposal: The company sold its Senior Housing assets (SH1) in September 2025, recording a minor loss of $0.1 million on the sale, eliminating the "Senior Housing" segment from future reporting.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Outlook
Management expects continued investment in clinical and operational value initiatives to offset rising cost of care. The company is focused on growing enrollment in existing centers and expanding via joint ventures (e.g., Tampa, Orlando). However, growth in California is currently constrained by a state moratorium on new PACE applications, which paused applications for a minimum of two years (excluding Downey and Bakersfield).
Key Risks and Contingencies
- Regulatory & Legal: The company is subject to ongoing civil investigative demands from the DOJ and the Colorado Attorney General regarding Medicaid billing and patient services. Losses from these matters cannot currently be estimated. Additionally, a stockholder class action lawsuit was settled for $27.0 million (with $10.1 million deposited in escrow), and a derivative suit is settled in principle with expected insurance funding.
- Macroeconomic & Policy: The "One Big Beautiful Bill Act" (OBBBA) mandates significant reductions in federal Medicaid spending and introduces new work requirements, potentially leading to downward pressure on capitation rates and enrollment delays.
- Operational: Labor shortages in geriatrics and primary care continue to drive wage inflation. Access to supportive housing facilities remains uncertain due to high demand.
Investor Verification Checklist
- California Expansion Status: Verify the timeline for lifting the California moratorium on new PACE centers and the status of the Corrective Action Plan (CAP) for the San Bernardino center.
- Medicaid Rate Impact: Monitor state budget processes to assess the actual impact of the OBBBA on Medicaid capitation rates and enrollment eligibility.
- Legal Exposure: Track the resolution of DOJ civil investigative demands and the final court approval of the stockholder derivative suit settlement.
- Pharmacy Transition: Evaluate the long-term cost savings and operational efficiency of the in-house pharmacy services transition following the TRHC asset acquisition.
- Debt Covenants: Confirm continued compliance with the secured net leverage ratio and other covenants under the amended Credit Agreement.